Page 144 - FINAL PROGRAMME 2017
P. 144

11:00 O-225
Single embryo transfer on cleavage-stage(D3) using Time-lapse selection VS on blastocyst(D5) using traditional morphological selection in patients with good prognosis: a prospective randomized controlled trial
L. Yang1, X. Kong2, S. Zhang3,4, J. Dai3, F. Gong2,5, G. Lu5,6,7, G. Lin2,5,6,7
1Institute of Reproducitve and Stem Cell Engineering, Basic Medicine College-Central South University, Changsha- Hunan, China
2Institute of Reproducitve and Stem Cell Engineering, Basic Medicine College- Central South University, Changsha, China
3Reproductive and Genetic Hospital of CITIC-XIANGYA, IVF laboratory, ChangSha, China
4Institute of Reproducitve and Stem Cell Engineering, Basic Medicine College-Central South University, ChangSha, China
5Reproductive and Genetic Hospital of CITIC-XIANGYA, Reproductive Center, ChangSha, China 6National Engineering and Research Center of Human Stem Cell, ChangSha, China
7Key Laboratory of Reproductive and Stem Cell Engineering, Ministry of Health, ChangSha, China
Time-lapse (TL) morphokinetic parameters do not predict the outcome of fresh In-Vitro Fertilization/Single Embryo Transfer (IVF/SET) cycles
G. Christou1, I. Dimitriadis2, L. Bourke3, S.T. McLellan3, P. Blowmick4, C.L. Bormann2, I. Souter2
1Harvard School of Public Health, Environmental and Occupational Medicine and Epidemiology, Boston, U.S.A.
2Harvard Medical School - Massachusetts General Hospital, Obstetrics and Gynecology/ Reproductive Endocrinology and Infertility, Boston- MA, U.S.A.
3Massachusetts General Hospital Fertility Center, Obstetrics and Gynecology/Reproductive Endocrinology and Infertility, Boston- MA, U.S.A.
4Massachusetts General Hospital Fertility Center, Obstetrics and Gynecology/Reproductive Endocrinology and Infertility, Boston, U.S.A.
Comparison of morphokinetic markers which predict blastocyst formation and implantation potential from two large clinical datasets; CRM, WCM, U.S.A. and IVI, Spain
N. Zaninovic1, Q. Zhan2, Z. Rosenwaks2, N. Basile3, A. Pellicer4, M. Meseguer5 1The Center for Reproductive Medicine and Infertility, New York- NY, U.S.A. 2CRM- Weill Cornell Medicine, Reproductive Medicine, New York, U.S.A.
3IVI Madrid, IVF, Marrid, Spain
4IVI Rome, IVF, Rome, Italy
5IVI Valencia, IVF, Valencia, Spain
11:15 O-226
11:30 O-227
144


































































































   142   143   144   145   146